These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29507503)

  • 1. Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome.
    Roy C; Adam JP; Morin F; Lemieux-Blanchard É; Doucet S; Friedmann D; Belisle A; Charpentier D
    Curr Oncol; 2018 Feb; 25(1):e103-e105. PubMed ID: 29507503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse events induced by azacitidine in myelodysplastic syndrome patients: Case reports and a lesson from published work review.
    Shimoda-Komatsu Y; Mizukawa Y; Takayama N; Ohyama M
    J Dermatol; 2020 Apr; 47(4):363-368. PubMed ID: 32056290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelodysplastic syndrome with neutrophilic dermatosis successfully treated with azacitidine].
    Kudo D; Shimizu M; Kuroda A; Suyama T; Shinagawa A; Ito S
    Rinsho Ketsueki; 2017; 58(6):607-612. PubMed ID: 28679990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of pyoderma gangrenosum and sweet's syndrome in a patient with ulcerative colitis.
    Ajili F; Souissi A; Bougrine F; Boussetta N; Abdelhafidh NB; Sayhi S; Louzir B; Doss N; Laabidi J; Othmani S
    Pan Afr Med J; 2015; 21():151. PubMed ID: 26327988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-Operative Pyoderma Gangrenosum: A Long Journey for a Patient with Myelodysplastic Syndrome.
    Tagliaferri AR
    Cureus; 2020 Aug; 12(8):e9984. PubMed ID: 32983685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual case of extracutaneous pyoderma gangrenosum with myelodysplastic syndrome.
    Zhang LL; Pan HX; Tong S; Liu L
    Int J Clin Exp Pathol; 2019; 12(9):3675-3678. PubMed ID: 31934219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum following cytosine arabinoside, aclarubicin and granulocyte colony-stimulating factor combination therapy in myelodysplastic syndrome.
    Takagi S; Ohsaka A; Taguchi H; Kusama H; Matsuoka T
    Intern Med; 1998 Mar; 37(3):316-9. PubMed ID: 9617871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of pyoderma gangrenosum that developed in a patient with myelodysplastic syndrome.
    Yamauchi T; Ishida K; Iwashima Y; Ikegaya S; Kawai Y; Wakahara M; Kumakiri M; Ueda T
    J Infect Chemother; 2003 Sep; 9(3):268-71. PubMed ID: 14513399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Malignancy-Associated Atypical Neutrophilic Dermatosis With Noninfectious Shock.
    Kinser KN; Panach K; Dominguez AR
    Am J Med Sci; 2017 Dec; 354(6):626-632. PubMed ID: 29208261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient].
    Maksimovic L; Duriez P; Lascaux-Cametz AS; Andre C; Bagot M; Revuz J; Ortonne N
    Ann Dermatol Venereol; 2010 May; 137(5):386-90. PubMed ID: 20470922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum in a cesarean section wound in a woman with myelodysplastic syndrome: A case report.
    Suzuki N; Murata T; Fukuda T; Kanno A; Kyozuka H; Yasuda S; Yamaguchi A; Fujimori K
    Case Rep Womens Health; 2020 Oct; 28():e00253. PubMed ID: 32963967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Deep-seated granulomatous pyoderma gangrenosum: A novel variant?].
    Baline K; Khadir K; Chiheb S; Marnissi F; Benchikhi H
    Ann Dermatol Venereol; 2015 May; 142(5):340-5. PubMed ID: 25637110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive Facial Ulcer: A Case Report of Pyoderma gangrenosum.
    Zhang XQ; Tang ZW; Jing J
    J Inflamm Res; 2024; 17():687-691. PubMed ID: 38332897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutrophilic dermatosis in a patient with refractory anemia].
    Banno S; Nitta M; Wakita A; Iwaki O; Takada K; Mitomo Y; Yamamoto M; Morita A; Tsuji T; Kunimatsu M
    Rinsho Ketsueki; 1992 May; 33(5):700-5. PubMed ID: 1630024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perineal pyoderma gangrenosum in pregnancy: A case report.
    Ohmaru-Nakanishi T; Goto H; Maehara M; Oishi H; Ueoka Y
    Case Rep Womens Health; 2019 Apr; 22():e00102. PubMed ID: 30976523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma.
    You HR; Ju JK; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    Ann Dermatol; 2018 Feb; 30(1):79-82. PubMed ID: 29386837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyoderma Gangrenosum Induced by BNT162b2 COVID-19 Vaccine in a Healthy Adult.
    Barry M; AlRajhi A; Aljerian K
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum-like lesions in the setting of IgA cutaneous vasculitis: Favourable response to adalimumab.
    Sugino H; Kawahara H; Yamamoto K; Okada E; Sawada Y
    Skin Health Dis; 2024 Apr; 4(2):e347. PubMed ID: 38577052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.